Funding for this research was provided by:
Singapore Immunology Network (F00006)
Text and Data Mining valid from 2019-08-31
First Online: 31 August 2019
Compliance with Ethical Standards
: MS, SWDL, EST, HHO, and ECR have no conflicts of interest that are directly relevant to the content of this article.
: This study was funded by Singapore Immunology Network F00006 core fund.
: This clinical study was approved by the IRB on “Genetic susceptibility in psoriasis with psoriatic arthritis and metabolic syndrome” (IRB number 2014/01132) and conducted according to the principles of the Declaration of Helsinki.